|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,850 KRW | -1.02% |
|
+0.10% | -22.03% |
Ensol Biosciences Inc. announced a private placement of 550,055 shares at an issue price of KRW 9,090 for a gross proceeds of KRW 4,999,999,950 on February 10, 2023. The transaction will include participation from Humedix Co., Ltd. for 550,055 shares. The company issued shares through third party allocation method and are restricted to the hold period of 1 year.
The transaction is expected to close on February 20, 2023. The transaction has been approved by the board of directors of the company.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 33,750 KRW | +0.75% | +2.90% | 253M | ||
| 4,850 KRW | -1.02% | +0.10% | 30.7M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| -22.03% | 30.7M | |
| -3.46% | 102B | |
| +1.41% | 96.29B | |
| +2.13% | 22.18B | |
| -15.84% | 21.2B | |
| -9.21% | 18.31B | |
| -39.98% | 17.38B | |
| -14.65% | 16.36B | |
| +4.39% | 13.97B | |
| +31.35% | 12.17B |
ENSOL BIOSCIENCES INC. 
